Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Use of pro-atrial natriuretic peptide in the detection of myocardial ischaemia.

Bocek T, Morgenthaler NG, Staub D, Nusbaumer C, Christ A, Zellweger MJ, Mueller-Brand J, Mueller B, Perruchoud AP, Mueller C.

Eur J Clin Invest. 2005 Jul;35(7):450-6.

PMID:
16008547
2.

Delayed release of brain natriuretic peptide to identify myocardial ischaemia.

Zürcher S, Honegger U, Wagener M, Lee G, Stallone F, Marxer T, Puelacher C, Schumacher C, Sou SM, Twerenbold R, Reichlin T, Hochgruber T, Tanglay Y, Freese M, Wild D, Rentsch K, Osswald S, Zellweger M, Mueller C.

Eur J Clin Invest. 2015 Nov;45(11):1175-83. doi: 10.1111/eci.12535. Epub 2015 Oct 7.

PMID:
26331403
3.

B-type natriuretic peptide and clinical judgment in the detection of exercise-induced myocardial ischemia.

Lee G, Sou SM, Twerenbold R, Reichlin T, Oshima S, Hochgruber T, Zürcher S, Matter D, Tanglay Y, Freese M, Honegger U, Wild D, Rentsch K, Osswald S, Zellweger MJ, Mueller C.

Am J Med. 2014 May;127(5):427-35. doi: 10.1016/j.amjmed.2014.01.009. Epub 2014 Jan 28.

PMID:
24486287
4.

Use of copeptin in the detection of myocardial ischemia.

Staub D, Morgenthaler NG, Buser C, Breidthardt T, Potocki M, Noveanu M, Reichlin T, Bergmann A, Mueller C.

Clin Chim Acta. 2009 Jan;399(1-2):69-73. doi: 10.1016/j.cca.2008.09.016. Epub 2008 Sep 21.

PMID:
18848827
5.

Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.

J Am Coll Cardiol. 2008 May 13;51(19):1857-64. doi: 10.1016/j.jacc.2008.01.041.

6.

Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.

Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.

J Intern Med. 2006 Dec;260(6):568-76.

7.

Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.

Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.

Am J Cardiol. 2012 Apr 15;109(8):1117-23. doi: 10.1016/j.amjcard.2011.11.047. Epub 2012 Jan 17.

PMID:
22257708
8.

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia.

De Greef J, Funk M, Vermaak WJ, Perumal NS, Libhaber CD, Vangu MD.

Cardiovasc J Afr. 2008 Sep-Oct;19(5):264-7.

9.

Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging.

Zaid G, Tanchilevitch A, Rivlin E, Gropper R, Rosenschein U, Lanir A, Goldhammer E.

Int J Cardiol. 2007 Apr 25;117(2):157-64. Epub 2006 Sep 25.

PMID:
16997398
10.

Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.

Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.

Int J Cardiol. 2008 Aug 18;128(2):244-9. Epub 2007 Jul 27.

PMID:
17673312
11.

MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.

Lindberg S, Jensen JS, Pedersen SH, Galatius S, Goetze JP, Mogelvang R.

Eur J Prev Cardiol. 2015 Jun;22(6):693-700. doi: 10.1177/2047487314538856. Epub 2014 Jun 6.

PMID:
24906365
12.

Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

van der Vekens N, Decloedt A, de Clercq D, Ven S, Sys S, van Loon G.

Equine Vet J. 2016 Jan;48(1):15-20. doi: 10.1111/evj.12362. Epub 2014 Nov 24.

PMID:
25257480
13.

Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.

Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C.

Heart. 2012 Oct;98(20):1518-22. Epub 2012 Aug 3.

PMID:
22865868
14.

Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia.

Wermuth J, Staub D, Laule-Kilian K, Nusbaumer C, Breidthardt T, Hochholzer W, Christ M, Mueller C.

Int J Cardiol. 2007 Aug 21;120(2):248-53. Epub 2006 Dec 19.

PMID:
17182131
15.

Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.

Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, Mueller-Brand J, Perruchoud AP, Mueller C.

Am J Med. 2005 Nov;118(11):1287.

PMID:
16271916
16.

Use of B-type natriuretic peptide in the detection of myocardial ischemia.

Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, Mueller-Brand J, Perruchoud AP, Mueller C.

Am Heart J. 2006 Jun;151(6):1223-30.

PMID:
16781223
17.

N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification.

Hunter I, Alehagen U, Dahlström U, Rehfeld JF, Crimmins DL, Goetze JP.

Clin Chem. 2011 Sep;57(9):1327-30. doi: 10.1373/clinchem.2011.166330. Epub 2011 Jun 29.

19.

Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.

von Haehling S, Papassotiriou J, Hartmann O, Doehner W, Stellos K, Geisler T, Wurster T, Schuster A, Botnar RM, Gawaz M, Bigalke B.

Clin Sci (Lond). 2012 Nov;123(10):601-10. doi: 10.1042/CS20120216.

PMID:
22690794

Supplemental Content

Support Center